• Title/Summary/Keyword: Thoracic tumor

Search Result 1,185, Processing Time 0.022 seconds

Low Grade Fibromyxoid Sarcoma of the Visceral Pleura - A case report - (장측 늑막에서 발생한 저등급 섬유점액성 육종 - 1예 보고 -)

  • Kim, Yeon-Soo;Chang, Sun-Hee;Lee, Sung-Soon;Ryoo, Ji-Yoon;Park, Kyung-Taek;Chang, Woo-Ik;Kim, Chang-Young;Cho, Seong-Joon
    • Journal of Chest Surgery
    • /
    • v.41 no.1
    • /
    • pp.141-144
    • /
    • 2008
  • Low grade fibromyxoid sarcoma (LGFM) is a rare, deep soft-tissue malignant tumor. Although its histologic features are benign, the clinical course is malignant. The usual tumor locations are the lower extremity and chest wall. LGFM originating from the visceral pleura is extremely rare. We report here on a 37 year old man with a LGFM of the visceral pleura. Thirty three months after surgery, the patient is alive without any sign of local recurrence or distant metastasis.

En Bloc Resection of a Thoracic Outlet for a Recurred Malignant Schwannoma of the Brachial Plexus - A case report - (상완신경총에 재발한 악성 신경초종에 대한 흉곽출구의 광범위 구역절제술 치험 - 1예 보고 -)

  • Kim, Young-Kyu;Park, Chin-Su;Son, Bong-Su;Kim, Yeong-Dae
    • Journal of Chest Surgery
    • /
    • v.40 no.10
    • /
    • pp.715-718
    • /
    • 2007
  • Neurogenic tumors of the brachial plexus are rare. An malignant schwannoma originates from the schwan cells or nerve sheath cells. Occasionally, schwannomas are associated with Von Rechlinghausen's disease, but this is rare. We were recently presented with a thirty-five year old female patient with a history of pulmonary tuberculosis about ten years prior. The patient also presented with a mass that has been slowly growing for one year. Onset of pain occurred six months after the tumor began to grow. The mass was $5{\times}7cm$ in size. The patient underwent on bloc resection of the tumor as the mass recurred twice in spite of postoperative radiotherapy.

Retrospective Analysis of Thoracoscopic Surgery for Esophageal Submucosal Tumors

  • Kang, Seung Ku;Yun, Ju Sik;Kim, Sang Hyung;Song, Sang Yun;Jung, Yochun;Na, Kook Joo
    • Journal of Chest Surgery
    • /
    • v.48 no.1
    • /
    • pp.40-45
    • /
    • 2015
  • Background: Surgical enucleation is the treatment of choice for esophageal submucosal tumors (SMTs) with symptomatic, larger, or ill-defined lesions. The enucleation of SMTs has traditionally been performed via thoracotomy. However, minimally invasive approaches have recently been introduced and successfully applied. In this study, we present our experiences with the thoracotomic and thoracoscopic approaches to treating SMTs. Methods: We retrospectively reviewed 53 patients with SMTs who underwent surgical enucleation between August 1996 and July 2013. Demographic and clinical features, tumor-related factors, the surgical approach, and outcomes were analyzed. Results: There were 36 males (67.9%) and 17 females (32.1%); the mean age was $49.2{\pm}11.8$ years (range, 16 to 79 years). Histology revealed leiomyoma in 51 patients, a gastrointestinal stromal tumor in one patient, and schwannoma in one patient. Eighteen patients (34.0%) were symptomatic. Fourteen patients underwent a planned thoracotomic enucleation. Of the 39 patients for whom a thoracoscopic approach was planned, six patients required conversion to thoracotomy because of overly small tumors or poor visualization in five patients and accidental mucosal injury in one patient. No mortality or major postoperative complications occurred. Compared to thoracotomy, the thoracoscopic approach had a slightly shorter operation time, but this difference was not statistically significant ($120.0{\pm}45.6$ minutes vs. $161.5{\pm}71.1$ minutes, p=0.08). A significant difference was found in the length of the hospital stay ($9.0{\pm}3.2$ days vs. $16.5{\pm}5.4$ days, p<0.001). Conclusion: The thoracoscopic enucleation of submucosal esophageal tumors is safe and is associated with a shorter length of hospital stay compared to thoracotomic approaches.

Long-Term Outcomes in Stage I Lung Cancer After Segmentectomy with a Close Resection Margin

  • Kim, Dae Hyeon;Na, Kwon Joong;Park, In Kyu;Kang, Chang Hyun;Kim, Young Tae;Park, Samina
    • Journal of Chest Surgery
    • /
    • v.54 no.5
    • /
    • pp.361-368
    • /
    • 2021
  • Background: In general, a 2-cm surgical margin is recommended for limited resection to obtain equivalent oncologic outcomes to lobectomy for lung cancer. This study aimed to examine the patterns of recurrence and prognostic factors for recurrence in patients with a close parenchymal resection margin. Methods: From January 2009 to April 2017, 156 patients with stage I lung cancer who underwent segmentectomy with a close resection margin (<2 cm) were enrolled. Recurrence-free survival and overall survival were assessed. In addition, predisposing factors for recurrence were evaluated. Results: The mean tumor size was 1.7±0.8 cm and the parenchymal resection margin was 1.1±0.6 cm. Recurrence developed in 17 (10.7%) of the 156 patients, and the 5-year recurrence-free survival rate was 88.9%. Distant metastasis (7.7%) was the predominant recurrence pattern. The isolated local recurrence rate was 1.9%. Multivariate Cox regression analysis revealed that age, tumor size, mediastinal lymph node dissection, postoperative complications, and histologic type were significant predisposing factors for recurrence. However, parenchymal margin distance did not significantly affect the long-term prognosis. Conclusion: Segmentectomy with a close resection margin for early-stage lung cancer in selected patients resulted in acceptable recurrence and survival. However, patients with tumors larger than 2 cm, squamous cell carcinoma histology, and insufficient mediastinal evaluation should be carefully followed up for recurrence.

Potential Survival Benefit of Upfront Surgery for Lung Tumors Unconfirmed but Highly Suspicious for Stage I Lung Cancer

  • Murat Kara;Eren Erdogdu;Salih Duman;Gulnar Fatalizade;Berker Ozkan;Alper Toker
    • Journal of Chest Surgery
    • /
    • v.57 no.5
    • /
    • pp.440-446
    • /
    • 2024
  • Background: Patients with early-stage lung tumors that are highly suspicious for malignancy typically undergo a preoperative diagnostic workup, primarily through bronchoscopy or transthoracic biopsy. Those without a preoperative diagnosis may alternatively be treated with upfront surgery, contingent upon the potential for intraoperative diagnosis. Previous studies have yielded conflicting results regarding the impact of upfront surgery on the survival of these patients. Our study aimed to elucidate the effect of upfront surgery on the survival outcomes of patients undergoing surgery for early-stage lung cancer without a preoperative diagnosis. Methods: We analyzed the survival rate of 158 consecutive patients who underwent pulmonary resection for stage I lung cancer, either with or without a preoperative diagnosis. Results: A total of 86 patients (54%) underwent upfront surgery. This approach positively impacted both disease-free survival (p=0.031) and overall survival (p=0.017). However, no significant differences were observed across subgroups based on sex, smoking status, forced expiratory volume in 1 second, histologic tumor size, or histologic subtype. Univariate analysis identified upfront surgery (p=0.020), age (p=0.002), maximum standardized uptake value (SUVmax) exceeding 7 (p=0.001), and histological tumor size greater than 20 mm (p=0.009) as independent predictors. However, multivariate analysis indicated that only SUVmax greater than 7 (p=0.011) was a significant predictor of unfavorable survival. Conclusion: Upfront surgery does not appear to confer a survival advantage in patients with stage I lung cancer undergoing surgical intervention.

Pulmonary Leiomyoma; A Case Report (폐 평활근종 치험 1례)

  • 홍기표
    • Journal of Chest Surgery
    • /
    • v.26 no.9
    • /
    • pp.735-737
    • /
    • 1993
  • We have experienced a case of leiomyoma in the right upper lobe of the lung in a 56 year old female. Preoperative studies revealed the tumor nature as benign, and we chose right upper lobectomywith video-assisted thoracoscope rather than with the usual posterolateral thoracotomy. Postoperativehistological diagnosis was pulmonary leiomyoma which is a rare type of benign lung tumor.

  • PDF

Mucoepidermoid Tumor OF LUNG: Report Of A Case (폐에 발생한 점액성 상피종 1례 보고)

  • 조광현
    • Journal of Chest Surgery
    • /
    • v.11 no.3
    • /
    • pp.269-272
    • /
    • 1978
  • Mucoepidermoid tumors of lung are extremely uncommon, with fewer than 50 such cases having been reported. The degree of tumor malignancy has been discussed by some authors without any definite conclusion. This report describes a case of this, occurred in a 53-year-old female, having a highly malignant process and finally confirmed by postoperative histopathological evaluation.

  • PDF

Intr apulmonary Hamartoma - 2 Case Report - (폐 과오종: 2례 보고)

  • 김형준
    • Journal of Chest Surgery
    • /
    • v.25 no.6
    • /
    • pp.577-580
    • /
    • 1992
  • We experienced two cases of pulmonary hamartoma, which is the most common benign tumor of lung. But the hamartoma is rare disease, because the most neoplasm of the is malignant. The importence of pulmonary hamartoma is the necessity of differential diagnosis between lung cancer and benign tumor of the lung. Recently, the development of FNAB [Fine needle aspiration biopsy] shows accurate diagnostic results.

  • PDF

Extraskeletal Ewing`s sarcoma in mediastinum A case report (종격동에 발생한 Extraskeletal Ewing`s Sarcoma치험 1례)

  • 나명훈
    • Journal of Chest Surgery
    • /
    • v.18 no.4
    • /
    • pp.867-871
    • /
    • 1985
  • The Ewing`s sarcoma is the primary malignant bone tumor but the tumor also occurs as a primary soft tissue neoplasm without involvement of bone. Here is presented a case of extraskeletal Ewing`s sarcoma in the posterior and superior mediastinum with review of literature. To our knowledge, this is the first case report of extraskeletal Ewing`s sarcoma in Korea.

  • PDF